[ADJUSTMENTS IN THE ORAL DRUG TREATMENT OF BARIATRIC PATIENTS].
Bariatric surgery continues to be a durable therapeutic option for a growing number of obese patients. The patients that are admitted to our hospital for elective bariatric procedures often suffer from multiple co-morbidities and are therefore treated with a significant number of chronic medications. These operations lead to drastic modifications of the anatomy and physiology of the gastro-intestinal tract that may change the pharmacokinetics of drugs. In addition, the natural post-operative course of a bariatric procedure may lead to amelioration or even resolution of some of the obesity-related chronic diseases, consequently eliminating the need for drug therapy. In this article we review various common situations which we face when managing bariatric patients' drug therapy and discuss possible solutions while optimizing drug therapy in this challenging patient population.